Table 1.
Recombinant protein | Clinical sample | |||||||
---|---|---|---|---|---|---|---|---|
Reactivity | PfLDH (n = 8) | PmLDH (n = 8) | PoLDH (n = 8) | PvLDH (n = 8) | P. falciparum (n = 29) | P. malariae (n = 15) | P. ovale (n = 4) | P. vivax (n = 58) |
Pan/Pf ratio |
Pan/Pv ratio |
Pan/Pf ratio |
Pan/Pv ratio |
|||||
Range | 0.82–1.13 | 3.59–5.49 | 1.89–4.38 | 1.38–2.6 | 0.56 − 2.61 | 3.43–6.54 | 4.07–5.16 | 1.37–2.79 |
Mean | 1.03 | 4.25 | 3.10 | 2.26 | 1.12 | 4.56 | 4.56 | 2.24 |
SD | 0.1 | 0.78 | 1.04 | 0.38 | 0.55 | 1.0 | 0.46 | 0.37 |
t-test | – | – | – | – | P = 0.63 | P = 0.33 | P = 0.27 | P = 0.89 |
Pan/Pf = PanLDH/PfLDH; Pan/Pv = PanLDH/PvLDH. Descriptive statistics for the ratio of PanLDH concentration to PfLDH or PvLDH concentration as indicated, determined via the 5-Plex. Any clinical samples that showed unquantifiable or infection-negative test results by the 5-Plex were excluded from analysis. P values correspond to comparison of different antigen sources.